Ignite Creation Date:
2024-05-05 @ 5:07 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00395967
Status:
TERMINATED
Last Update Posted:
2015-05-01
First Post:
2006-11-02
Brief Title:
AMD3100 Plerixafor in Multiple Myeloma MM or Non-Hodgkins Lymphoma NHL Patients Predicted to be Unable to Mobilize With G-CSF Alone
Sponsor:
Genzyme a Sanofi Company
Organization:
Sanofi
Organization Data
Organization:
Sanofi
Class:
INDUSTRY
Study ID:
AMD3100-2109
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Genzyme a Sanofi Company
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Medical Monitor
Old Organization:
Genzyme Corporation